Utilizing the Dural Substitute Confetti technique during spinal cord stimulation trial implantation may reduce complications and shorten surgery time.

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

HFX iQ is the first and only spinal cord stimulation (SCS) system integrating high-frequency SCS landmark ... The Senza HFX ...

The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system ... The Senza ...

Mississauga, Ontario--(Newsfile Corp. - November 11, 2024) - MyndTec Inc (CSE: MYTC). ("MyndTec" or the "Company"), a medical technology company focused on neurological treatment, rehabilitation and ...

In the study, "Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations in Schizophrenia: A Randomized Clinical Trial," published in JAMA Network Open, the team investigated ...

Chris Patterson retired before Christmas 2022, after falling and breaking his back. He has faced several issues trying to get ...

In this week’s edition of The Prototype, we look at a new way to help kids with a certain neurological disorder walk again, a ...

Philadelphia-based Rothman Orthopaedic Institute has been at the forefront of spine care, and recently a team partnered with Thomas Jefferson University Hospita ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...